紫杉醇药物洗脱支架在冠心病介入治疗中的研究进展(3)
 |
| 第1页 |
参见附件(2663KB，5页)。
[12] Degertekin M,Regar E,Tanabe K,et al.Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease[J].Minerva Cardioangiol,2002,50(5):405-418.
[13] Chieffo A,Colombo A.Drug-eluting stents[J].Minerva Cardioangiol,2002,50(5):419-429.
[14] Drachman DE，Edelman ER，Seifert P，et al.Neointimal thickening after stent delivery of paclitaxel:Change in composition and arrest of growth over six months[J].J Am Coll Cardiol,2000,36(7):2325-2332.
[15] Scollott SJ,Cheng L,Pauly RR,et al.Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat[J].J Clin Invest,1995,95(4):1869-1876.
[16] Axel DI,Kunert W,Goglmann C,et al.Paclitaxel inhibits arterial smooth muscle proliferation and migration in vitro and in vivousing local drug delivery[J].Circulation,1997,96(3):635-645.
[17] Heldman AW，Cheng L，Jenkins GM，et al.Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis[J].Circulation,2001,103(18):2289-2295.
[18] Farb A，Heller PF，Shroff S，et al.Pathological analysis of local delivery of paclitaxel via a polymer-coated stent[J].Circulation，2001,104(4):473-479.
[19] Kolodgie FD，John M，Khurana C，et al.Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel[J].Circulation,2002,106(10):1195-1198.
[20] Grube E， Silber S， HauptmanKE,et al.First five-year clinical follow-up from a randomized trial of a polymer-based,paclitaxel-eluting stent:TAXUS-Ⅰ[J].J Am Coll Cardiol,2006,98(8A):141 ......
您现在查看是摘要介绍页，详见PDF附件(2663KB，5页)。